Executive Committee:
- Gordon McCauley, President and CEO, adMare BioInnovations (Chair)
- Roberto Bellini, President & CEO, BSQUARED Capital (Vice Chair)
- Oliver Technow, CEO, BioVectra Inc. (Treasurer)
- Andrew Casey, President & CEO, BIOTECanada (Secretary)
- Paul Petrelli, President & CEO, Jazz Pharmaceuticals (Former Chair)
Directors
- Norma Biln, CEO, Augurex
- Colleen Coxson, Country Manager, Alnylam Pharmaceuticals
- Andrew Haigh, President and CEO, Adapsyn Bioscience
- Maha Katabi, General Partner, Sofinnova Ventures
- Brigitte Nolet, President & CEO, Roche Canada Pharma
- Nancy Pei, Partner, Smart & Biggar
- Najah Sampson, President, Pfizer Canada Inc.
- Sanj Singh, President & CEO, Temple Therapeutics B.V.
- Jamie Stiff, Managing Director, Genesys Capital
- Ali Tehrani, Tehrani, Partner, Amplitude Ventures